https://camrelizumabinhibitor.....com/wip1-worsens-the
We aimed to assess the accuracy regarding the LAP list to determine MS in individuals living with HIV. TECHNIQUES It is a cross-sectional study with 141 HIV-infected patients on antiretroviral therapy, performed in a reference center of infectious diseases in southeast Brazil. Evaluations included LAP list, anthropometric measurements and clinical and laboratorial variables. MS had been defined by Global Diabetes Federation (IDF) criteria. RESULTS The prevalence of MS within ou
Aimer
Commentaire
Partagez
